Daphnane Diterpenoids from <i>Trigonostemon lii</i> and Inhibition Activities Against HIV-1

doi:10.1007/s13659-020-00231-7

Natural Products and Bioprospecting

2020, Vol. 10

Issue (1) : 37-44 DOI: 10.1007/s13659-020-00231-7

ORIGINAL ARTICLES

Daphnane Diterpenoids from Trigonostemon lii and Inhibition Activities Against HIV-1

Cheng-Jian Tan^1,3, Shi-Fei Li^1,4, Ning Huang^2,5, Yu Zhang¹, Ying-Tong Di¹, Yong-Tang Zheng², Xiao-Jiang Hao¹

1 State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650204, Yunnan, People's Republic of China;
2 Key Laboratory of Bioactive Peptides of Yunnan Province/Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences, Center for Biosafety Mega-Science, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, Yunnan, People's Republic of China;
3 School of Ethnic Medicine, Guizhou Minzu University, Guiyang 550025, Guizhou, People's Republic of China;
4 Institute of Molecular Science, Shanxi University, Taiyuan 030006, Shanxi, People's Republic of China;
5 School of Basic Medical, Kunming Medical University, Kunming 650500, Yunnan, People's Republic of China

Abstract
References
Related Articles
Metrics

Download: PDF(4348 KB) HTML (126)
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract Natural products are the important source for the discovery of more potent anti-HIV agents. In this study, six daphnane diterpenoids including three unreported structures were isolated from Trigonostemon lii, which showed significant activities against HIV-1 strains replication in the nanomolar/picomolar range. Meanwhile, these diterpenoids significantly inhibited the fusion of H9/HIV-1 IIIB cells with uninfected C8166 cells, with the EC_50s from 1.06 to 8.73 ng/mL, and did not show any inhibition activities against HIV-1 reverse transcriptase. Moreover, all of the diterpenoids shows significant inhibitions against T20-resistan HIV-1 strains, PNL4-3gp41(36G)V38E, N42S and pNL4-3gp41(36G)V38A, N42T. The results revealed that the six diterpenoids could be a new type of potential lead candidate as an HIV entry inhibitor, particularly for those infected by T20-resistant variants.

Keywords Trigonostemon lii Daphnane diterpenoid Trigonolactone Anti-HIV

Fund:This work was supported financially by grants from the National Science Foundation of China (21432010 and 81660612) and Technological leading talent project of Yunnan (2015HA020). Yunnan Applied Basic Research Project-Kunming Medical University Union Foundation (2017FE467 (-127), Scientific Research Fund Projects from the Department of Education of Yunnan (2016ZDX042) and the HundredTalent Program of Kunming Medical University (60117190441).

Corresponding Authors: Yong-Tang Zheng, Xiao-Jiang Hao E-mail: zhengyt@mail.kiz.ac.cn;haoxj@mail.kib.ac.cn

Issue Date: 29 February 2020

	Service

	E-mail this article
	E-mail Alert
	RSS
	Articles by authors

	Cheng-Jian Tan
	Shi-Fei Li
	Ning Huang
	Yu Zhang
	Ying-Tong Di
	Yong-Tang Zheng
	Xiao-Jiang Hao

Trendmd:

Cite this article:

Cheng-Jian Tan,Shi-Fei Li,Ning Huang, et al. Daphnane Diterpenoids from Trigonostemon lii and Inhibition Activities Against HIV-1[J]. Natural Products and Bioprospecting, 2020, 10(1): 37-44.

URL:

http://npb.kib.ac.cn/EN/10.1007/s13659-020-00231-7 OR http://npb.kib.ac.cn/EN/Y2020/V10/I1/37

1. M. Youcef, E.D. Clercq, J. Med. Chem. 53, 521-538 (2010)
2. M.J. Marrazzo, C. Del Rio, D.R. Holtgrave, M.S. Cohen, S.C. Kalichman, K.H. Mayer, J.S. Montaner, D.P. Wheeler, R.M. Grant, B. Grinsztejn, N. Kumarasamy, S. Shoptaw, R.P. Walensky, F. Dabis, J. Sugarman, C.A. Benson, JAMA 312, 390-409 (2014)
3. M.I. Qadir, S.A. Malik, Rev. Med. Virol. 20, 23-33 (2010)
4. I.P. Singh, H.S. Bodiwala, Nat. Prod. Rep. 27, 1781-1800 (2010)
5. I.W. Park, C.R. Han, X.P. Song, L.A. Green, T. Wang, Y. Liu, C.C. Cen, X.M. Song, B. Yang, G.Y. Chen, J.J. He, BMC Compl. Altern. Med. 9, 29 (2009). https://doi.org/10.1186/1472-6882-9-29
6. Y.Y. Cheng, H. Chen, H.P. He, Y. Zhang, S.F. Li, G.H. Tang, L.L. Guo, W. Yang, F. Zhu, Y.T. Zheng, S.L. Li, X.J. Hao, Phytochemistry 96, 360-369 (2013)
7. X.J. Hao, Y.T. Zheng, H.P. He, N. Huang, C.J. Tan, C.Y. Li, Y.T. Di, R.R. Wang, China. Patent CN 102101864A (2011)
8. P.M. Allard, P. Leyssen, M.T. Martin, M. Bourjot, V. Dumontet, C. Eydoux, J.C. Guillemot, B. Canard, C. Poullain, F. Gueritte, M. Litaudon, Phytochemistry 84, 160-168 (2012)
9. M. Bourjot, P. Leyssen, J. Neyts, V. Dumontet, M. Litaudon, Molecules 19, 3617-3627 (2014)
10. S.G. Liao, H.D. Chen, J.M. Yue, Chem. Rev. 109, 1092-1140 (2009)
11. J. Lu, S.G. Deeks, R. Hoh, G. Beatty, B.A. Kuritakes, J.N. Martin, D.R. Kuritzkes, J. Acquir. Immune Defic. Syndr. 43, 60-64 (2006)
12. P.R. Sista, T. Melby, D. Davison, L. Jin, S. Mosier, M. Mink, E.L. Nelson, R. DeMasi, N. Cammack, M.P. Salgo, T.J. Matthews, M.L. Greenberg, AIDS 18, 1787-1794 (2004)
13. X.P. Wei, J.M. Decker, H.M. Liu, Z. Zhang, R.B. Arani, J.M. Kilby, M.S. Saag, X.Y. Wu, G.M. Shaw, J.C. Kappes, Antimicrob. Agents Chemother. 46, 1896-1905 (2002)
14. L. Zhang, R.H. Luo, F. Wang, M.Y. Jiang, Z.J. Dong, L.M. Yang, Y.T. Zheng, J.K. Liu, Org. Lett. 12, 152-155 (2010)
15. L. Zhang, R.H. Luo, F. Wang, Z.J. Dong, L.M. Yang, Y.T. Zheng, J.K. Liu, Phytochemistry 71, 1879-1883 (2010)
16. A.M. Vandamme, M. Witvrou, C. Pannecouque, J. Balzarini, K.V. Laethem, J.C. Schmit, J. Desmyter, E. De, Clercq, Antiviral Methods and Protocols (Humanae Press, Clifton., 2000)
17. Y.T. Zheng, W.F. Zhang, K.L. Ben, J.H. Wang, Immunopharmacol. Immunotoxicol. 17, 69-79 (1995)
18. N. Huang, M.Y. Wu, C.B. Zheng, L. Zhu, J.H. Zhao, Y.T. Zheng, Carbohydr. Res. 380, 64-69 (2013)
19. R.R. Wang, Q. Gu, L.M. Yang, J.J. Chen, S.Y. Li, Y.T. Zheng, J. Ethnopharmacol. 105, 269-273 (2006)
20. Q. Wang, Z.H. Ding, J.K. Liu, Y.T. Zheng, Antiviral Res. 64, 189-194 (2004)

[1]	Shi-Fei LI, Yuan-Yuan CHENG, Yu ZHANG, Shun-Lin LI, Hong-Ping HE, Xiao-Jiang HAO. β-Carboline alkaloids from Trigonostemon filipes and Trigonostemon lii[J]. Natural Products and Bioprospecting, 2012, 2(3): 126-129.

Viewed

Full text

Abstract

Cited

Shared

Discussed